Abstract |
The effect of once daily doses of 200 mg oral norfloxacin on the occurrence of catheter-associated bacteriuria (greater than 1000 CFU/ml) and pyuria was studied in 105 post-operative gynaecologic patients. Norfloxacin was given from the second day after surgery until catheter removal. Bacteriuria developed in 32 of 51 (63%) control patients compared to 8 of 54 (15%) patients receiving norfloxacin (p less than 0.001). Pyuria was present in 22 of 51 (43%) control subjects versus only 3 of 54 (5%) patients treated with norfloxacin (p less than 0.001). Bacteria isolated from control patients comprised species of Enterobacteriaceae (40%), Staphylococcus (35%), and Streptococcus (17%); seven isolates were resistant to multiple antibiotics reflecting their nosocomial origin. In contrast, strains isolated from norfloxacin-treated patients comprised non-fermenting gram-negative rods (79%, usually Alcaligenes or Acinetobacter spp.) and faecal streptococci (12%). It is concluded that once daily doses of 200 mg oral norfloxacin are effective in reducing the rate of catheter-associated bacteriuria and pyuria following reconstructive gynaecologic surgery.
|
Authors | H A Verbrugh, A J Mintjes-de Groot, R Andriesse, K Hamersma, A van Dijk |
Journal | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
(Eur J Clin Microbiol Infect Dis)
Vol. 7
Issue 4
Pg. 490-4
(Aug 1988)
ISSN: 0934-9723 [Print] Germany |
PMID | 3141155
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Alcaligenes
(isolation & purification)
- Bacteriuria
(prevention & control)
- Catheters, Indwelling
- Cross Infection
(prevention & control)
- Enterobacteriaceae
(isolation & purification)
- Female
- Humans
- Middle Aged
- Norfloxacin
(therapeutic use)
- Pyuria
(prevention & control)
- Staphylococcus
(isolation & purification)
- Streptococcus
(isolation & purification)
- Urinary Catheterization
|